€116.58
Your prediction
Agilent Technologies Inc. Stock
Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."
Pros and Cons of Agilent Technologies Inc. in the next few years
Pros
Cons
Performance of Agilent Technologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | -0.410% | -6.874% | -2.531% | 6.225% | -7.242% | -6.688% | 75.082% |
| QuidelOrtho Corp. | -0.680% | -5.195% | -28.431% | -60.805% | -56.945% | -72.348% | - |
| Boston Scientific | 0.000% | -1.379% | 2.143% | 44.299% | 38.997% | 93.087% | 88.505% |
| Waters Corp. | -0.260% | -1.158% | -6.796% | 7.602% | -12.351% | -11.767% | 42.067% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon initial review, the financials of Agilent Technologies (US Symbol: A) from the Healthcare Equipment & Supplies industry appear to show steady growth and financial stability. The company has managed to increase its net income and total assets over the past few years, suggesting a strong and expanding financial position. This combined with a generally positive industry trend makes Agilent Technologies an interesting player in the healthcare equipment and supplies sector.
Pros
Revenue Growth: From 2020 to 2022, Agilent's total revenue increased from $5.34 billion to $6.85 billion, demonstrating consistent growth. This steady uptick in revenues suggests promising business prospects and an expanding market share in the industry.
Comments
News
Agilent Names Bret DiMarco Chief Legal Officer
Agilent Technologies, Inc. (NYSE: A) today announced Bret DiMarco has been named to lead the company’s global legal organization as senior vice president and chief legal officer, as well as serving
Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
Agilent Technologies Inc. (NYSE: A) today released the company’s annual ESG report, showcasing a comprehensive and growing set of sustainable solutions that enable hundreds of thousands of labs
Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
Agilent Technologies Inc., (NYSE: A) is introducing two new products at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. The Agilent 7010D Triple Quadrupole GC/MS System which